In 2010, the European market for cardiac surgery devices was valued at over'990 millionThe European markets for cardiac surgery devices includes: - Mechanical Heart Valves - Annuloplasty Repair Devices - Percutaneous Mitral Valve Repair Devices (PMVR) - Percutaneous Aortic Valve Replacement Devices (PAVR) - ONCAB Devices - OPCAB Devices - Endoscopic Vessel Harvesting Devices - Anastomosis Assist Devices - Cardiac Ablation Devices - Transmyocardial Revascularization Devices - Ventricular Assist Devices - Intra-Aortic Balloon Pump Devices - Artificial Heard Devices - Patient Foramen Ovale Devices - Atrial and Ventricular Septal DevicesThe countries covered in this report include: - Germany - France - U.K - Italy - Spain - Benelux - Scandinavia - Portugal - Austria - SwitzerlandWithin the European cardiac surgery device market, companies such as Edwards Lifesciences, Maquet, Medtronic, Sorin and St. Jude lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
European Markets for Interventional Cardiology Devices 2011 (15 Countries)ReportLinker.com
In 2010, the European markets for interventional cardiology devices were valued at over '1.5 billion. In 2010, the fastest growing European market for interventional cardiology devices as the United Kingdom. Over the forecast period, Scandinavia is expected to be the fastest growing market in Europe because it has relatively low DES penetration rates; as these penetration rates increase, they will boost market growth. Growth in countries such as Austria, France, and Switzerland are expected to slow over the forecast period due to decreases in prices across several device markets. The European markets, as defined in this report, include: - Germany, - France, - The United Kingdom (U.K.), - Italy, - Spain, - Benelux (Belgium, Netherlands, and Luxembourg), - Scandinavia (Finland, Denmark, Sweden, and Norway), - Portugal, - Austria and - SwitzerlandThe interventional cardiology market includes: - Drug-eluting stents, - Bare-metal stents, - PTCA balloon catheters, - Interventional coronary catheters and guidewires, - Diagnostic coronary catheters and guidewires, - Coronary introducer sheaths, - Embolic protection devices, - Atherectomy devices, - Coronary vascular closure devices, - Optical coherence tomography (OCT) catheters - Intravascular ultrasound (IVUS) cathetersIn addition, this report covers the emerging markets for vulnerable plaque screening and treatment. Within the European interventional cardiology market, companies such as Boston Scientific, Abbott Laboratories, Cordis and Medtronic lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
European Market for Cardiac Rhythm Management, Electrophysiology & Ablation D...ReportLinker.com
European Market for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 (15 countries) In 2010, the European market for cardiac rhythm management, electrophysiology, and ablation devices was valued at over '2.3 billion ($3.09 billion). The fastest growth was expected in the diagnostic electrophysiology (EP) catheter market and the slowest growth was expected in the external defibrillators market. None of the markets covered in this report are expected to decline over the forecast period. The countries covered in this report include: - Germany - France - U.K - Italy - Spain - Benelux - Scandinavia - Portugal - Austria - SwitzerlandThe market segments in this report include: - Pacemakers, - Implantable cardioverter-defibrillators (ICDs), - Cardiac resynchronization therapy devices (CRTs), - Cardiac leads, - External defibrillators, - Ablation catheters, - Intracardiac echocardiography (ICE) catheters and - Diagnostic electrophysiology (EP) cathetersWithin the cardiac rhythm management, electrophysiology, and ablation device market, companies such as Biotronik, Boston Scientific, Medtronic and St. Jude Medical lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
The global interventional cardiology and peripheral vascular devices market was valued at $8.7 billion in 2011 and is expected to grow to $12.7 billion by 2016. The market consists of devices used in coronary and peripheral endovascular procedures. Major drivers of growth include increasing demand for minimally invasive treatments and rising rates of coronary and peripheral artery diseases. North America currently dominates the market but Asia is growing the fastest.
Intravascular ultrasound (ivus) global trends, estimates and forecasts, 201...Research Hub
The document summarizes a research report on the global trends in the intravascular ultrasound (IVUS) market from 2012-2018. Some key points:
- The global IVUS market is projected to reach $618 million by 2016, with North America and Europe currently making up about half the market and Asia-Pacific being the fastest growing region.
- IVUS catheters make up about half the market, while IVUS consoles and accessories comprise the other half. The report provides an analysis of the market size, trends, technologies and investment opportunities in the IVUS sector by region.
Hemodynamic monitoring devices emerging markets (brazil, russia, india, chi...Research Hub
The document summarizes a market research report on hemodynamic monitoring devices in emerging markets from 2012-2018. It finds that the BRICSS market for these devices is expected to reach $281 million by 2016, driven primarily by cardiac output monitoring devices. China and India make up nearly half of the total market share. The report provides an overview of cardiovascular diseases and devices, hemodynamic monitoring technologies, key players in the various regional markets, and market trends and forecasts through 2018.
The global Peripheral Vascular Devices market is segregated on the basis of Product as EVAR Stent Grafts, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, and Other Devices.
Cardiac defibrillators emerging markets (brazil, russia, india, china, sout...Research Hub
The document summarizes a research report on the cardiac defibrillators market in emerging markets like Brazil, Russia, India, China, South Africa, and South Korea from 2012-2018. Some key points:
- The market is expected to reach $1.5 billion by 2016, led by implantable cardioverter defibrillators and external defibrillating devices.
- China accounts for 27.4% of the market and India for 23.8%. China has the fastest growth while India and South Korea have strong growth.
- The report analyzes market trends, segments, technologies, competitors and provides investment strategies.
Global in vitro diagnostics (ivd) market (technique, product, usability, appl...Allied Market Research
The in vitro diagnostics market is expected to reach $74.65 billion by 2020, growing at a rate of 5.34% annually from $53.32 billion in 2013. North America currently generates the highest revenue, while Asia Pacific is the fastest growing region. Key drivers are increasing healthcare spending and advancements in diagnostic technologies. Hospitals and laboratories are the largest end users. The report provides an in-depth analysis of the market size, trends, opportunities, and competitive landscape by technique, product type, application, end user, and region.
European Markets for Interventional Cardiology Devices 2011 (15 Countries)ReportLinker.com
In 2010, the European markets for interventional cardiology devices were valued at over '1.5 billion. In 2010, the fastest growing European market for interventional cardiology devices as the United Kingdom. Over the forecast period, Scandinavia is expected to be the fastest growing market in Europe because it has relatively low DES penetration rates; as these penetration rates increase, they will boost market growth. Growth in countries such as Austria, France, and Switzerland are expected to slow over the forecast period due to decreases in prices across several device markets. The European markets, as defined in this report, include: - Germany, - France, - The United Kingdom (U.K.), - Italy, - Spain, - Benelux (Belgium, Netherlands, and Luxembourg), - Scandinavia (Finland, Denmark, Sweden, and Norway), - Portugal, - Austria and - SwitzerlandThe interventional cardiology market includes: - Drug-eluting stents, - Bare-metal stents, - PTCA balloon catheters, - Interventional coronary catheters and guidewires, - Diagnostic coronary catheters and guidewires, - Coronary introducer sheaths, - Embolic protection devices, - Atherectomy devices, - Coronary vascular closure devices, - Optical coherence tomography (OCT) catheters - Intravascular ultrasound (IVUS) cathetersIn addition, this report covers the emerging markets for vulnerable plaque screening and treatment. Within the European interventional cardiology market, companies such as Boston Scientific, Abbott Laboratories, Cordis and Medtronic lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
European Market for Cardiac Rhythm Management, Electrophysiology & Ablation D...ReportLinker.com
European Market for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 (15 countries) In 2010, the European market for cardiac rhythm management, electrophysiology, and ablation devices was valued at over '2.3 billion ($3.09 billion). The fastest growth was expected in the diagnostic electrophysiology (EP) catheter market and the slowest growth was expected in the external defibrillators market. None of the markets covered in this report are expected to decline over the forecast period. The countries covered in this report include: - Germany - France - U.K - Italy - Spain - Benelux - Scandinavia - Portugal - Austria - SwitzerlandThe market segments in this report include: - Pacemakers, - Implantable cardioverter-defibrillators (ICDs), - Cardiac resynchronization therapy devices (CRTs), - Cardiac leads, - External defibrillators, - Ablation catheters, - Intracardiac echocardiography (ICE) catheters and - Diagnostic electrophysiology (EP) cathetersWithin the cardiac rhythm management, electrophysiology, and ablation device market, companies such as Biotronik, Boston Scientific, Medtronic and St. Jude Medical lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
The global interventional cardiology and peripheral vascular devices market was valued at $8.7 billion in 2011 and is expected to grow to $12.7 billion by 2016. The market consists of devices used in coronary and peripheral endovascular procedures. Major drivers of growth include increasing demand for minimally invasive treatments and rising rates of coronary and peripheral artery diseases. North America currently dominates the market but Asia is growing the fastest.
Intravascular ultrasound (ivus) global trends, estimates and forecasts, 201...Research Hub
The document summarizes a research report on the global trends in the intravascular ultrasound (IVUS) market from 2012-2018. Some key points:
- The global IVUS market is projected to reach $618 million by 2016, with North America and Europe currently making up about half the market and Asia-Pacific being the fastest growing region.
- IVUS catheters make up about half the market, while IVUS consoles and accessories comprise the other half. The report provides an analysis of the market size, trends, technologies and investment opportunities in the IVUS sector by region.
Hemodynamic monitoring devices emerging markets (brazil, russia, india, chi...Research Hub
The document summarizes a market research report on hemodynamic monitoring devices in emerging markets from 2012-2018. It finds that the BRICSS market for these devices is expected to reach $281 million by 2016, driven primarily by cardiac output monitoring devices. China and India make up nearly half of the total market share. The report provides an overview of cardiovascular diseases and devices, hemodynamic monitoring technologies, key players in the various regional markets, and market trends and forecasts through 2018.
The global Peripheral Vascular Devices market is segregated on the basis of Product as EVAR Stent Grafts, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, and Other Devices.
Cardiac defibrillators emerging markets (brazil, russia, india, china, sout...Research Hub
The document summarizes a research report on the cardiac defibrillators market in emerging markets like Brazil, Russia, India, China, South Africa, and South Korea from 2012-2018. Some key points:
- The market is expected to reach $1.5 billion by 2016, led by implantable cardioverter defibrillators and external defibrillating devices.
- China accounts for 27.4% of the market and India for 23.8%. China has the fastest growth while India and South Korea have strong growth.
- The report analyzes market trends, segments, technologies, competitors and provides investment strategies.
Global in vitro diagnostics (ivd) market (technique, product, usability, appl...Allied Market Research
The in vitro diagnostics market is expected to reach $74.65 billion by 2020, growing at a rate of 5.34% annually from $53.32 billion in 2013. North America currently generates the highest revenue, while Asia Pacific is the fastest growing region. Key drivers are increasing healthcare spending and advancements in diagnostic technologies. Hospitals and laboratories are the largest end users. The report provides an in-depth analysis of the market size, trends, opportunities, and competitive landscape by technique, product type, application, end user, and region.
European Markets for Spinal Implants and VCF 2011ReportLinker.com
iData's comprehensive European Markets for Spinal Implants and VCF 2010 report is the industry leading research report for actionable market intelligence in the changing and exciting European spine industry. This report denotes key data points, market trends, and in-depth analysis for the following market segments: - Cervical fusion, - Thoracolumbar fusion, - Interbody fusion (including stand-alone interbody devices), - Vertebroplasty, - Kyphoplasty, - Artificial discs, - Interspinous distraction devices, - Dynamic stabilization, - Annular repair, - Nucleus replacement, - Facet arthroplasty and lumbar and - Cervical electrical stimulation devices.This report also includes key data from the minimally invasive spinal (MIS) fusion market, including XLIF, AxiaLIF, GLIF, DLIF, MIS PLIF and MIS TLIF approaches.The report covers: - Austria - Benelux - France - Germany - Portugal - Scandinavia - Spain - Switzerland - The United KingdomThe European spinal implant markets are expected to exceed '1 billion by 2017,driven by growth in non-fusion devices. Within the European spinal implant market, companies such as Depuy, Medtronic, Stryker, Synthes and Zimmer lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available.
European Markets for Anesthesia, Respiratory and Sleep Apnea Devices 2011ReportLinker.com
In 2011, the European Market for Anesthesia, Respiratory and Sleep Management Devices was valued at over $1.4 billion. By 2017, this market is expected to reach almost $2 billion, fueled by growth in the sleep therapy device and ventilator segments, the market is expected to increase over the forecast period. As the population increases in age, the prevalence of sleep disorders is expected to grow accordingly. The European population is also becoming more aware of sleep disorders and the risks associated with not receiving proper treatment, which will drive the total market for anesthesia, respiratory and sleep management devices. In addition, technological advancements such as remote monitoring and homecare devices are expected to further fuel growth. The market segments covered in this report include: - Anesthesia Delivery Units - Anesthesia Delivery Market - Anesthesia Disposables - Ventilators - Nebulizers - Respiratory Disposables - Sleep Diagnostic Devices - Sleep Therapy Devices The countries covered in this report include: - Austria - Benelux - France - Germany - Italy - Portugal - Scandinavia - Spain - Switzerland - The United KingdomThis report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
Asia-Pacific Markets for Patient Monitoring Devices 2011ReportLinker.com
The total Asia-Pacific patient monitoring market is expected to exceed $598 million by 2017. The Australian home telehealth market experienced the greatest growth in revenues of over 90% in 2010, followed by the Japanese wireless ambulatory telemetry market. Growth is being fueled by efforts of healthcare facilities to decrease costs and compensate for staff shortages by using technology to increase patient mobility and discharge patients sooner. In addition, wireless telemetry monitoring in the Asia-Pacific region was primarily utilized in cardiac care-related areas in 2010. However, expansion of telemetry to other hospital departments that previously did not have monitoring, many of which are low-acuity settings, is expected to drive growth in this market by 2017.The Asia-Pacific markets for patient monitoring devices includes the following countries: - Japan - Australia - South KoreaThe market segments covered in this report include: - Multi-parameter vital sign monitors - Intra-cranial pressure monitors and consumables - Electromyogram devices and consumables - Electroencephalogram monitors - Sleep apnea monitors - Cerebral oximeter monitors and consumables - Fetal and neonatal monitors - Pulse oximeter monitors, consumables and circuit boards - Cardiac output devices and consumables - Blood pressure monitorsWithin the Asia-Pacific patient monitoring market, companies such as Nihon Kohden, GE Healthcare and Philips Healthcare lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
Asia-Pacific Markets for Patient Monitoring Devices 2011ReportLinker.com
The total Asia-Pacific patient monitoring market is expected to exceed $598 million by 2017. The Australian home telehealth market experienced the greatest growth in revenues of over 90% in 2010, followed by the Japanese wireless ambulatory telemetry market. Growth is being fueled by efforts of healthcare facilities to decrease costs and compensate for staff shortages by using technology to increase patient mobility and discharge patients sooner. In addition, wireless telemetry monitoring in the Asia-Pacific region was primarily utilized in cardiac care-related areas in 2010. However, expansion of telemetry to other hospital departments that previously did not have monitoring, many of which are low-acuity settings, is expected to drive growth in this market by 2017.The Asia-Pacific markets for patient monitoring devices includes the following countries: - Japan - Australia - South KoreaThe market segments covered in this report include: - Multi-parameter vital sign monitors - Intra-cranial pressure monitors and consumables - Electromyogram devices and consumables - Electroencephalogram monitors - Sleep apnea monitors - Cerebral oximeter monitors and consumables - Fetal and neonatal monitors - Pulse oximeter monitors, consumables and circuit boards - Cardiac output devices and consumables - Blood pressure monitorsWithin the Asia-Pacific patient monitoring market, companies such as Nihon Kohden, GE Healthcare and Philips Healthcare lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
Asia-Pacific Markets for Patient Monitoring Devices 2011ReportLinker.com
The total Asia-Pacific patient monitoring market is expected to exceed $598 million by 2017. The Australian home telehealth market experienced the greatest growth in revenues of over 90% in 2010, followed by the Japanese wireless ambulatory telemetry market. Growth is being fueled by efforts of healthcare facilities to decrease costs and compensate for staff shortages by using technology to increase patient mobility and discharge patients sooner. In addition, wireless telemetry monitoring in the Asia-Pacific region was primarily utilized in cardiac care-related areas in 2010. However, expansion of telemetry to other hospital departments that previously did not have monitoring, many of which are low-acuity settings, is expected to drive growth in this market by 2017.The Asia-Pacific markets for patient monitoring devices includes the following countries: - Japan - Australia - South KoreaThe market segments covered in this report include: - Multi-parameter vital sign monitors - Intra-cranial pressure monitors and consumables - Electromyogram devices and consumables - Electroencephalogram monitors - Sleep apnea monitors - Cerebral oximeter monitors and consumables - Fetal and neonatal monitors - Pulse oximeter monitors, consumables and circuit boards - Cardiac output devices and consumables - Blood pressure monitorsWithin the Asia-Pacific patient monitoring market, companies such as Nihon Kohden, GE Healthcare and Philips Healthcare lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
European Markets for Orthopedic Large Joint Reconstructive Devices 2011ReportLinker.com
In 2010, the combined European large joint orthopedic reconstruction device market was valued at over '1.9 billion. The countries covered in this report include: - Austria - Benelux - France - Germany - Italy - Portugal - Scandinavia - Spain - Switzerland - The United KingdomDespite the lower average selling prices offered in the German reconstruction device market, which had the most challenging pricing environment, it was the largest combined hip and knee reconstruction device market in Europe. Comparatively, the average price for orthopedic implants in Germany was lower than for Portugal, which has a significantly lower national income per capita. The market segments covered in this report include: - The knee reconstruction market - The hip reconstruction market - The bone cement marketWithin the orthopedic large joint replacement and bone cement market, companies such as Biomet, DePuy Orthopaedics, Smith & Nephew, Stryker Orthopedics and Zimmer lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tiss...ReportLinker.com
In 2010, the total European markets for dental bone graft substitutes and other biomaterials grew by 4.4% over 2009 and were valued at nearly '232 million. This market includes: - Austria - Benelux - France - Germany - Italy - Portugal - Scandinavia - Spain - Switzerland - U.K. This report also includes the following market segments: - Dental Bone Graft Substitute Market - Dental Autograft Potential Market - Dental Xenograft Market - Synthetic Bone Graft Substitute Materials Market - Dental Membrane Market Within the dental bone graft substitute market, companies such as Biomet-3i, Geistlich, Riemser (Curasan) and Non-Profit Tissue Banks lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
Asia Pacific Markets for Orthopedic Large Joint Reconstructive Devices 2011ReportLinker.com
This document provides a market analysis of orthopedic large joint reconstructive devices in Asia Pacific markets from 2011-2017. It finds that the combined markets of Australia, Japan, and South Korea for large joint implants was valued at over $1.65 billion in 2010, with hip and knee replacement implants representing a significant portion of healthcare expenditures. The report provides an in-depth analysis of the markets in these countries, including market size, forecasts, procedures, product segments, average selling prices, leading competitors, drivers and limiters.
This report provides a detailed analysis of the global catheter market, including different types of catheters used for cardiovascular, urological, intravenous, and other applications. It discusses key disease conditions driving catheter usage, trends in the overall medical device industry, and projections for catheter sales by region through 2018. The report also profiles major companies in the catheter market and their product portfolios.
Datamonitor's Electricity: Global Industry Guide is an essential resource for top-level data and analysis covering the Electricity industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.Scope of the Report * Contains an executive summary and data on value, volume and segmentation * Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies* Incorporates in-depth five forces competitive environment analysis and scorecards * Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US). * Includes a five-year forecast of the industryHighlightsThe global electricity market grew by 2.1% in 2009 to reach a value of $1,601.6 billion.In 2014, the global electricity market is forecast to have a value of $2,693.2 billion, an increase of 68.2% since 2009.The global electricity market shrank by 0.7% in 2009 to reach a volume of 15,302.5 Twh (Terawatt-hour).In 2014, the global electricity market is forecast to have a volume of 19,908.5 Twh (Terawatt-hour), an increase of 30.1% since 2009.Industry is the largest segment of the global electricity market, accounting for 37.9% of the market's total value.Asia-Pacific accounts for 40.4% of the global electricity market value.China Southern Power Grid is the leading player in the global electricity market, generating a 12.2% share of the market's volume.Rivalry in the global electricity market is moderate overall, although country-to-country variations are considerable. Why you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level researchMarket DefinitionThe electricity market consists of the sale of electricity to industrial, commercial, household, transportation, and other end-users, including agricultural. The volume of the market is calculated as the total volume of electricity consumed (in billions of kilowatt hours, kWh), and the market value has been calculated according to average annual electricity prices. Note that 1 TWh is identical to 1 billion kWh, or 1 million MWh. Market shares are calculated on the basis of retail sales to end-users in all segments. Any currency conversions used in the creation of this report have been calculated using constant 2009 annual average exchange rates.
Datamonitor's Suncare: Global Industry Guide is an essential resource for top-level data and analysis covering the Suncare industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.Scope of the Report * Contains an executive summary and data on value, volume and segmentation * Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies* Incorporates in-depth five forces competitive environment analysis and scorecards * Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US). * Includes a five-year forecast of the industryHighlightsThe global suncare market grew by 4.3% in 2009 to reach a value of $6,330.6 million.In 2014, the global suncare market is forecast to have a value of $7,911 million, an increase of 25% since 2009.The global suncare market grew by 3.1% in 2009 to reach a volume of 645.9 million units.In 2014, the global suncare market is forecast to have a volume of 755.9 million units, an increase of 17% since 2009.Sun protection is the largest segment of the global suncare market, accounting for 65.4% of the market's total value.Europe accounts for 39.8% of the global suncare market value.L'Oreal S.A. is the leading player in the global suncare market, generating a 13.7% share of the market's value.L'Oreal, Beiersdorf, and Johnson & Johnson are leading players in the global suncare products market, each with a broad portfolio of brands, catering to different consumer groups and price points, with 36.3% of the market share in value termsWhy you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level researchMarket DefinitionThe suncare market consists of retail sale of sun protection, after-sun and self-tan products. The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2009 annual average exchange rates.
The document summarizes a report on the LTCC (low-temperature co-fired ceramic) market from 2020 to 2025. It discusses key aspects of the LTCC market like end users, material types, process types, and regional analysis. The LTCC market is segmented based on end user industries like automotive, telecommunications, aerospace & defense, and medical. LTCC is commonly used in applications requiring multi-chip modules, high-frequency modules, capacitors, conductors, inductors, and transformers. The report also analyzes the market size and forecast for major regions like North America, Europe, and Asia Pacific.
There will be a steady increase in demand for new diagnostic testing services in the next five-year period, along with pressures to improve the quality of healthcare delivered in the clinic and also to lower its costs. Clinical labs experienced a substantial growth during the last decade.
European Electronic Cigarette and Vaporizer Market 2015-2025Sukrit Shah
The document provides an overview of the European electronic cigarette and vaporizer market from 2015 to 2025. It discusses key topics like market size and segmentation, major players, regulations and directives in different European countries, patents, and market forecasts. The European e-cigarette market is expected to grow to over $17 billion by 2025, driven by factors like product innovation and customization options. Regulations vary across countries in Europe.
This document provides an overview and market analysis of the neurointerventional devices market from 2010 to 2017. It states that the global market was estimated at $1.25 billion in 2012 and is expected to grow at a 6.8% compound annual growth rate to $1.73 billion by 2017. The largest segment is aneurysm coiling and arteriovenous malformation embolization and fistula embolization. North America currently dominates the market but Asia-Pacific and Latin America are expected to grow faster due to increasing healthcare spending. The report covers market drivers, trends, competitive landscape and company profiles of major players.
The document discusses the extraction fans market. It provides an overview of key players in the extraction fans market and segments the market by type of extraction fan (portable vs stationary) and applications (residential, commercial, industrial, others). Extraction fans are used to remove airborne contaminants from industrial processes. The report analyzes market trends, growth prospects, challenges, and individual company profiles of the top players in the extraction fans industry. It aims to provide a comprehensive analysis of the current state and future outlook of the global extraction fans market.
In the last five decades, electronic cardiac medicine has witnessed dramatic technological developments. The cardiac rhythm management products mainly marketed by a handful of global players are used to treat arrhythmias, specifically supraventricular arrhythmias (SVA) and ventricular arrhythmias (VA). The different types of SVA are premature atrial contractions (PAC), supraventricular tachycardia (SVT), sick sinus syndrome (SSS), atrial fibrillation (A-fib) and atrial flutter (AFL). Varying forms of VA are premature ventricular complex (PVC), ventricular tachycardia (VT) and ventricular fibrillation (VF). These cardiac disorders are treated with the aid of different types of electronic cardiac devices. This TriMark Publications report focuses on the global and regional markets for all cardiac rhythm management (CRM) devices, and includes data on implant volumes, procedure costs and reimbursement coverage. This study also covers in detail important areas within CRM such as: implantable cardioverter-defibrillators (ICDs), cardiovascular implantable electronic devices (CIEDs), resynchronisation therapy (CRT), implantable loop recorders (ILRs) and implantable hemodynamic monitoring (IHM).
2012 Global and China cardiac stent industry depth research reportReportsnReports
This 234-page report provides an in-depth analysis of the global and Chinese cardiac stent industry from 2009-2013. It covers topics such as market size, production capacity, market share, pricing, costs, and competitive landscape of the top 16 global and 6 Chinese companies. It also analyzes industry trends, opportunities, challenges, and provides strategic recommendations. The report aims to support customers in competitive analysis, development planning, and investment decision making within the cardiac stent industry.
Global ultrasonic welding machine industry 2017 market research reportQYResearch
The document provides an overview and analysis of the global ultrasonic welding machine industry in 2017. It discusses key topics such as market size, classifications of ultrasonic welding machines, major manufacturers and their profiles, production costs, consumption trends, and the development outlook for the industry. Major regions and companies in the ultrasonic welding machine market are also analyzed.
Downstream processing in biopharmaceuticals adoptionRose088
This document summarizes a report from GBI Research about downstream processing in biopharmaceuticals. It discusses the adoption of disposable technologies at larger economies of scale to optimize production efficiency and cost-effectiveness. The report provides an overview of the biopharmaceutical and contract manufacturing industries as well as the downstream processing and reagent markets. It also includes market data, forecasts, profiles of key players, and an analysis of drivers and restraints. The report aims to help readers develop market strategies and understand factors shaping the industries.
Smartphones: When is the first and last time you check yours?ReportLinker.com
Nearly half (46%) of Americans say they check their smartphones as soon as they wake up, while they’re still in bed, according to ReportLinker’s survey results. This is especially true of Millennials, 66% of whom say it’s the first thing they do before getting out of bed.
75% of Ameircans say they keep their smartphones active all day and night, and a staggering 83% of Millennials say they do.
In fact, disconnecting can be hard. More than half of Americans say their last check is right before bed – and 13% say they disconnect only after they’ve gotten into bed for the night. Even after they fall asleep, about 10% say they’ll wake up and check it during the night.
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoReportLinker.com
ReportLinker and Findout use data analytics technologies to aggregate and normalize data from a wide range of sources to help researchers and analysts find relevant information more efficiently. The companies' core competency lies in both search and data analytics capabilities. Their natural language processing platform analyzes millions of documents daily to extract and structure concepts, relationships, and sentiments to improve users' productivity. Open data initiatives have helped the businesses by providing more content to incorporate, though most value comes from backend processing rather than raw data access. The companies aim to continue enhancing data discovery and contextualization of results.
More Related Content
Similar to European Markets for Cardiac Surgery Devices
European Markets for Spinal Implants and VCF 2011ReportLinker.com
iData's comprehensive European Markets for Spinal Implants and VCF 2010 report is the industry leading research report for actionable market intelligence in the changing and exciting European spine industry. This report denotes key data points, market trends, and in-depth analysis for the following market segments: - Cervical fusion, - Thoracolumbar fusion, - Interbody fusion (including stand-alone interbody devices), - Vertebroplasty, - Kyphoplasty, - Artificial discs, - Interspinous distraction devices, - Dynamic stabilization, - Annular repair, - Nucleus replacement, - Facet arthroplasty and lumbar and - Cervical electrical stimulation devices.This report also includes key data from the minimally invasive spinal (MIS) fusion market, including XLIF, AxiaLIF, GLIF, DLIF, MIS PLIF and MIS TLIF approaches.The report covers: - Austria - Benelux - France - Germany - Portugal - Scandinavia - Spain - Switzerland - The United KingdomThe European spinal implant markets are expected to exceed '1 billion by 2017,driven by growth in non-fusion devices. Within the European spinal implant market, companies such as Depuy, Medtronic, Stryker, Synthes and Zimmer lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available.
European Markets for Anesthesia, Respiratory and Sleep Apnea Devices 2011ReportLinker.com
In 2011, the European Market for Anesthesia, Respiratory and Sleep Management Devices was valued at over $1.4 billion. By 2017, this market is expected to reach almost $2 billion, fueled by growth in the sleep therapy device and ventilator segments, the market is expected to increase over the forecast period. As the population increases in age, the prevalence of sleep disorders is expected to grow accordingly. The European population is also becoming more aware of sleep disorders and the risks associated with not receiving proper treatment, which will drive the total market for anesthesia, respiratory and sleep management devices. In addition, technological advancements such as remote monitoring and homecare devices are expected to further fuel growth. The market segments covered in this report include: - Anesthesia Delivery Units - Anesthesia Delivery Market - Anesthesia Disposables - Ventilators - Nebulizers - Respiratory Disposables - Sleep Diagnostic Devices - Sleep Therapy Devices The countries covered in this report include: - Austria - Benelux - France - Germany - Italy - Portugal - Scandinavia - Spain - Switzerland - The United KingdomThis report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
Asia-Pacific Markets for Patient Monitoring Devices 2011ReportLinker.com
The total Asia-Pacific patient monitoring market is expected to exceed $598 million by 2017. The Australian home telehealth market experienced the greatest growth in revenues of over 90% in 2010, followed by the Japanese wireless ambulatory telemetry market. Growth is being fueled by efforts of healthcare facilities to decrease costs and compensate for staff shortages by using technology to increase patient mobility and discharge patients sooner. In addition, wireless telemetry monitoring in the Asia-Pacific region was primarily utilized in cardiac care-related areas in 2010. However, expansion of telemetry to other hospital departments that previously did not have monitoring, many of which are low-acuity settings, is expected to drive growth in this market by 2017.The Asia-Pacific markets for patient monitoring devices includes the following countries: - Japan - Australia - South KoreaThe market segments covered in this report include: - Multi-parameter vital sign monitors - Intra-cranial pressure monitors and consumables - Electromyogram devices and consumables - Electroencephalogram monitors - Sleep apnea monitors - Cerebral oximeter monitors and consumables - Fetal and neonatal monitors - Pulse oximeter monitors, consumables and circuit boards - Cardiac output devices and consumables - Blood pressure monitorsWithin the Asia-Pacific patient monitoring market, companies such as Nihon Kohden, GE Healthcare and Philips Healthcare lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
Asia-Pacific Markets for Patient Monitoring Devices 2011ReportLinker.com
The total Asia-Pacific patient monitoring market is expected to exceed $598 million by 2017. The Australian home telehealth market experienced the greatest growth in revenues of over 90% in 2010, followed by the Japanese wireless ambulatory telemetry market. Growth is being fueled by efforts of healthcare facilities to decrease costs and compensate for staff shortages by using technology to increase patient mobility and discharge patients sooner. In addition, wireless telemetry monitoring in the Asia-Pacific region was primarily utilized in cardiac care-related areas in 2010. However, expansion of telemetry to other hospital departments that previously did not have monitoring, many of which are low-acuity settings, is expected to drive growth in this market by 2017.The Asia-Pacific markets for patient monitoring devices includes the following countries: - Japan - Australia - South KoreaThe market segments covered in this report include: - Multi-parameter vital sign monitors - Intra-cranial pressure monitors and consumables - Electromyogram devices and consumables - Electroencephalogram monitors - Sleep apnea monitors - Cerebral oximeter monitors and consumables - Fetal and neonatal monitors - Pulse oximeter monitors, consumables and circuit boards - Cardiac output devices and consumables - Blood pressure monitorsWithin the Asia-Pacific patient monitoring market, companies such as Nihon Kohden, GE Healthcare and Philips Healthcare lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
Asia-Pacific Markets for Patient Monitoring Devices 2011ReportLinker.com
The total Asia-Pacific patient monitoring market is expected to exceed $598 million by 2017. The Australian home telehealth market experienced the greatest growth in revenues of over 90% in 2010, followed by the Japanese wireless ambulatory telemetry market. Growth is being fueled by efforts of healthcare facilities to decrease costs and compensate for staff shortages by using technology to increase patient mobility and discharge patients sooner. In addition, wireless telemetry monitoring in the Asia-Pacific region was primarily utilized in cardiac care-related areas in 2010. However, expansion of telemetry to other hospital departments that previously did not have monitoring, many of which are low-acuity settings, is expected to drive growth in this market by 2017.The Asia-Pacific markets for patient monitoring devices includes the following countries: - Japan - Australia - South KoreaThe market segments covered in this report include: - Multi-parameter vital sign monitors - Intra-cranial pressure monitors and consumables - Electromyogram devices and consumables - Electroencephalogram monitors - Sleep apnea monitors - Cerebral oximeter monitors and consumables - Fetal and neonatal monitors - Pulse oximeter monitors, consumables and circuit boards - Cardiac output devices and consumables - Blood pressure monitorsWithin the Asia-Pacific patient monitoring market, companies such as Nihon Kohden, GE Healthcare and Philips Healthcare lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
European Markets for Orthopedic Large Joint Reconstructive Devices 2011ReportLinker.com
In 2010, the combined European large joint orthopedic reconstruction device market was valued at over '1.9 billion. The countries covered in this report include: - Austria - Benelux - France - Germany - Italy - Portugal - Scandinavia - Spain - Switzerland - The United KingdomDespite the lower average selling prices offered in the German reconstruction device market, which had the most challenging pricing environment, it was the largest combined hip and knee reconstruction device market in Europe. Comparatively, the average price for orthopedic implants in Germany was lower than for Portugal, which has a significantly lower national income per capita. The market segments covered in this report include: - The knee reconstruction market - The hip reconstruction market - The bone cement marketWithin the orthopedic large joint replacement and bone cement market, companies such as Biomet, DePuy Orthopaedics, Smith & Nephew, Stryker Orthopedics and Zimmer lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tiss...ReportLinker.com
In 2010, the total European markets for dental bone graft substitutes and other biomaterials grew by 4.4% over 2009 and were valued at nearly '232 million. This market includes: - Austria - Benelux - France - Germany - Italy - Portugal - Scandinavia - Spain - Switzerland - U.K. This report also includes the following market segments: - Dental Bone Graft Substitute Market - Dental Autograft Potential Market - Dental Xenograft Market - Synthetic Bone Graft Substitute Materials Market - Dental Membrane Market Within the dental bone graft substitute market, companies such as Biomet-3i, Geistlich, Riemser (Curasan) and Non-Profit Tissue Banks lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
Asia Pacific Markets for Orthopedic Large Joint Reconstructive Devices 2011ReportLinker.com
This document provides a market analysis of orthopedic large joint reconstructive devices in Asia Pacific markets from 2011-2017. It finds that the combined markets of Australia, Japan, and South Korea for large joint implants was valued at over $1.65 billion in 2010, with hip and knee replacement implants representing a significant portion of healthcare expenditures. The report provides an in-depth analysis of the markets in these countries, including market size, forecasts, procedures, product segments, average selling prices, leading competitors, drivers and limiters.
This report provides a detailed analysis of the global catheter market, including different types of catheters used for cardiovascular, urological, intravenous, and other applications. It discusses key disease conditions driving catheter usage, trends in the overall medical device industry, and projections for catheter sales by region through 2018. The report also profiles major companies in the catheter market and their product portfolios.
Datamonitor's Electricity: Global Industry Guide is an essential resource for top-level data and analysis covering the Electricity industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.Scope of the Report * Contains an executive summary and data on value, volume and segmentation * Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies* Incorporates in-depth five forces competitive environment analysis and scorecards * Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US). * Includes a five-year forecast of the industryHighlightsThe global electricity market grew by 2.1% in 2009 to reach a value of $1,601.6 billion.In 2014, the global electricity market is forecast to have a value of $2,693.2 billion, an increase of 68.2% since 2009.The global electricity market shrank by 0.7% in 2009 to reach a volume of 15,302.5 Twh (Terawatt-hour).In 2014, the global electricity market is forecast to have a volume of 19,908.5 Twh (Terawatt-hour), an increase of 30.1% since 2009.Industry is the largest segment of the global electricity market, accounting for 37.9% of the market's total value.Asia-Pacific accounts for 40.4% of the global electricity market value.China Southern Power Grid is the leading player in the global electricity market, generating a 12.2% share of the market's volume.Rivalry in the global electricity market is moderate overall, although country-to-country variations are considerable. Why you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level researchMarket DefinitionThe electricity market consists of the sale of electricity to industrial, commercial, household, transportation, and other end-users, including agricultural. The volume of the market is calculated as the total volume of electricity consumed (in billions of kilowatt hours, kWh), and the market value has been calculated according to average annual electricity prices. Note that 1 TWh is identical to 1 billion kWh, or 1 million MWh. Market shares are calculated on the basis of retail sales to end-users in all segments. Any currency conversions used in the creation of this report have been calculated using constant 2009 annual average exchange rates.
Datamonitor's Suncare: Global Industry Guide is an essential resource for top-level data and analysis covering the Suncare industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.Scope of the Report * Contains an executive summary and data on value, volume and segmentation * Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies* Incorporates in-depth five forces competitive environment analysis and scorecards * Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US). * Includes a five-year forecast of the industryHighlightsThe global suncare market grew by 4.3% in 2009 to reach a value of $6,330.6 million.In 2014, the global suncare market is forecast to have a value of $7,911 million, an increase of 25% since 2009.The global suncare market grew by 3.1% in 2009 to reach a volume of 645.9 million units.In 2014, the global suncare market is forecast to have a volume of 755.9 million units, an increase of 17% since 2009.Sun protection is the largest segment of the global suncare market, accounting for 65.4% of the market's total value.Europe accounts for 39.8% of the global suncare market value.L'Oreal S.A. is the leading player in the global suncare market, generating a 13.7% share of the market's value.L'Oreal, Beiersdorf, and Johnson & Johnson are leading players in the global suncare products market, each with a broad portfolio of brands, catering to different consumer groups and price points, with 36.3% of the market share in value termsWhy you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level researchMarket DefinitionThe suncare market consists of retail sale of sun protection, after-sun and self-tan products. The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2009 annual average exchange rates.
The document summarizes a report on the LTCC (low-temperature co-fired ceramic) market from 2020 to 2025. It discusses key aspects of the LTCC market like end users, material types, process types, and regional analysis. The LTCC market is segmented based on end user industries like automotive, telecommunications, aerospace & defense, and medical. LTCC is commonly used in applications requiring multi-chip modules, high-frequency modules, capacitors, conductors, inductors, and transformers. The report also analyzes the market size and forecast for major regions like North America, Europe, and Asia Pacific.
There will be a steady increase in demand for new diagnostic testing services in the next five-year period, along with pressures to improve the quality of healthcare delivered in the clinic and also to lower its costs. Clinical labs experienced a substantial growth during the last decade.
European Electronic Cigarette and Vaporizer Market 2015-2025Sukrit Shah
The document provides an overview of the European electronic cigarette and vaporizer market from 2015 to 2025. It discusses key topics like market size and segmentation, major players, regulations and directives in different European countries, patents, and market forecasts. The European e-cigarette market is expected to grow to over $17 billion by 2025, driven by factors like product innovation and customization options. Regulations vary across countries in Europe.
This document provides an overview and market analysis of the neurointerventional devices market from 2010 to 2017. It states that the global market was estimated at $1.25 billion in 2012 and is expected to grow at a 6.8% compound annual growth rate to $1.73 billion by 2017. The largest segment is aneurysm coiling and arteriovenous malformation embolization and fistula embolization. North America currently dominates the market but Asia-Pacific and Latin America are expected to grow faster due to increasing healthcare spending. The report covers market drivers, trends, competitive landscape and company profiles of major players.
The document discusses the extraction fans market. It provides an overview of key players in the extraction fans market and segments the market by type of extraction fan (portable vs stationary) and applications (residential, commercial, industrial, others). Extraction fans are used to remove airborne contaminants from industrial processes. The report analyzes market trends, growth prospects, challenges, and individual company profiles of the top players in the extraction fans industry. It aims to provide a comprehensive analysis of the current state and future outlook of the global extraction fans market.
In the last five decades, electronic cardiac medicine has witnessed dramatic technological developments. The cardiac rhythm management products mainly marketed by a handful of global players are used to treat arrhythmias, specifically supraventricular arrhythmias (SVA) and ventricular arrhythmias (VA). The different types of SVA are premature atrial contractions (PAC), supraventricular tachycardia (SVT), sick sinus syndrome (SSS), atrial fibrillation (A-fib) and atrial flutter (AFL). Varying forms of VA are premature ventricular complex (PVC), ventricular tachycardia (VT) and ventricular fibrillation (VF). These cardiac disorders are treated with the aid of different types of electronic cardiac devices. This TriMark Publications report focuses on the global and regional markets for all cardiac rhythm management (CRM) devices, and includes data on implant volumes, procedure costs and reimbursement coverage. This study also covers in detail important areas within CRM such as: implantable cardioverter-defibrillators (ICDs), cardiovascular implantable electronic devices (CIEDs), resynchronisation therapy (CRT), implantable loop recorders (ILRs) and implantable hemodynamic monitoring (IHM).
2012 Global and China cardiac stent industry depth research reportReportsnReports
This 234-page report provides an in-depth analysis of the global and Chinese cardiac stent industry from 2009-2013. It covers topics such as market size, production capacity, market share, pricing, costs, and competitive landscape of the top 16 global and 6 Chinese companies. It also analyzes industry trends, opportunities, challenges, and provides strategic recommendations. The report aims to support customers in competitive analysis, development planning, and investment decision making within the cardiac stent industry.
Global ultrasonic welding machine industry 2017 market research reportQYResearch
The document provides an overview and analysis of the global ultrasonic welding machine industry in 2017. It discusses key topics such as market size, classifications of ultrasonic welding machines, major manufacturers and their profiles, production costs, consumption trends, and the development outlook for the industry. Major regions and companies in the ultrasonic welding machine market are also analyzed.
Downstream processing in biopharmaceuticals adoptionRose088
This document summarizes a report from GBI Research about downstream processing in biopharmaceuticals. It discusses the adoption of disposable technologies at larger economies of scale to optimize production efficiency and cost-effectiveness. The report provides an overview of the biopharmaceutical and contract manufacturing industries as well as the downstream processing and reagent markets. It also includes market data, forecasts, profiles of key players, and an analysis of drivers and restraints. The report aims to help readers develop market strategies and understand factors shaping the industries.
Similar to European Markets for Cardiac Surgery Devices (20)
Smartphones: When is the first and last time you check yours?ReportLinker.com
Nearly half (46%) of Americans say they check their smartphones as soon as they wake up, while they’re still in bed, according to ReportLinker’s survey results. This is especially true of Millennials, 66% of whom say it’s the first thing they do before getting out of bed.
75% of Ameircans say they keep their smartphones active all day and night, and a staggering 83% of Millennials say they do.
In fact, disconnecting can be hard. More than half of Americans say their last check is right before bed – and 13% say they disconnect only after they’ve gotten into bed for the night. Even after they fall asleep, about 10% say they’ll wake up and check it during the night.
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoReportLinker.com
ReportLinker and Findout use data analytics technologies to aggregate and normalize data from a wide range of sources to help researchers and analysts find relevant information more efficiently. The companies' core competency lies in both search and data analytics capabilities. Their natural language processing platform analyzes millions of documents daily to extract and structure concepts, relationships, and sentiments to improve users' productivity. Open data initiatives have helped the businesses by providing more content to incorporate, though most value comes from backend processing rather than raw data access. The companies aim to continue enhancing data discovery and contextualization of results.
This graphic shows Samsung's customers are still loyal: 86% of Samsung Customers would consider Samsung next time they upgrade their smartphone. More info on reportlinker.com/inisght
This document provides a summary of a report on the European branded coffee shop market in 23 countries. Some key points:
- It examines the size and growth of the branded coffee shop market in each country from 2009-2015. Several countries like Poland and Spain saw strong growth over 10% in 2011-2012.
- Market leaders like Starbucks, Costa Coffee and Coffee Fellows are profiled for each country along with operating statistics and strategies. Consumer trends toward convenience and sustainability are also discussed.
- Challenges facing the industry like economic uncertainty and high rents are analyzed. Success factors include quality coffee, food offerings and a strong brand. The growth potential of each market is evaluated based on GDP per capita and existing
Allegra's definitive annual study on the UK branded coffee shop market is now available; with insight from over 25,000 consumers the report provides an authoritative view of the market.Drawing on more than 12 years in-depth research, it is considered to be the bible of the coffee sector.KEY AREAS COVERED' Market size and growth projections for the total UK market' Impact of recent economic downturn on trading performance' Key player profiles, including financial performance, pricing analysis and forecasts' Importance of ethical and sustainability issues' Key success factors and market trends' Opportunities and challenges for suppliers' Consumer coffee consumption patterns' Consumer brand awareness and perceptions of key players' Differences between customer demographics, including age, gender, occupation and location by the reportSOURCE OF INFORMATION' Interviews with CEOs, managing directors, senior managers and store managers of major industry players, including:' leading UK coffee and food-focused chains' major coffee roasters and key equipment suppliers' non-specialist players including department stores, supermarkets, bookstores' leading property companies, letting agents and landlords' local authorities' Online surveys with UK coffee shop visitors' Desk research including: News articles and trade press, the Internet and company websites,industry associations, published accounts, data supplied by operators' In-store observations and analysis
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...ReportLinker.com
WinterGreen Research announces that it has published a new study Wireless Infrastructure: Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. Next generation mission critical systems are leveraging new technology. The 2013 study has 554 pages, 245 tables and figures. Worldwide Wireless Infrastructure markets are poised to achieve significant growth as Building out core networks and backhaul for smart phones.A smart phone is not very smart if the infrastructure can't support its applications. In response to the high growth smart phone markets, wireless infrastructure promises to grow dramatically in the near term.. Wireless Infrastructure technologies include WiMax, LTE, 4G and HSPA. These technologies are driving much higher capacity from the base station back to the fiber core. Fiber core is putting extreme pressure on provider's infrastructure and backhaul networks.WinterGreen Research predicts that the dramatic growth of wireless infrastructure is based on the growth of smart phones to a one trillion market by 2019, serving an installed base of 8.5 billion, many people having more than one smart phone. Wireless infrastructure markets at $58 billion in 2012 will be $163 billion by 2019, new markets evolved because of the value that apps provide to smart phones, mobile devices, tablets, and the Internet of things.According to Susan Eustis, lead author of the study, 'Wireless Infrastructure is being installed to upgrade core networks and upgrade backhaul and base stations to make systems more modern. Infrastructure for the Internet and for smart mobile devices creates demand for more sophisticated web development and web applications that in turn depend on more sophisticated infrastructure. Everything is going mobile. This evolution is driven by mobile smart phones and tablets that provide universal connectivity. Modern systems represent a significant aspect of Internet market evolution.'The proportions of wireless infrastructure market industry segments are expected to remain much as they are, with the small cells and femtocells achieving strong growth on the access side, the core infrastructure must be upgraded to support the added backhaul backbone infrastructure. Wireless apps are expected to achieve $37 trillion revenue by 2019. This unbelievable growth occurs as the Internet is expanded to implement the interconnection of everything.Digital devices proliferate, machine to machine capabilities vastly expand instrumentation. The digital devices become the engine of a world economy, with apps collecting pennies a day for millions of apps from 8.5 billion people with smart phones by 2019.
This document is a fax order form for reports from ReportLinker, which provides industry reports, company profiles, and market statistics. It contains fields for customers to provide contact and billing information as well as select a payment method of credit card, wire transfer, or check in order to place an order for reports. The form directs customers to fax the completed form back to ReportLinker offices in either Europe, the Middle East, and Africa or Asia, Oceania, and America depending on location.
This document is a fax order form for industry reports and company profiles from ReportLinker. It contains fields for customers to provide their contact and shipping information as well as payment details including credit card number, expiration date, and CVV. The form also lists ReportLinker's fax numbers for customers in different regions to submit their orders.
This very short document contains a single word - "TEST" - with no other context provided. It is not possible to provide a meaningful summary in 3 sentences or less given the extremely limited information.
Global Electric Resistance Welded Pipes IndustryReportLinker.com
This report analyzes the worldwide markets for Electric Resistance Welded Pipes in Thousand Tons by the following Product Segments: Mechanical Steel Tubing, Structural Tubing, Structural Steel Pipes, Pressure Tubing, Standard Pipes, Oil Country Tubular Goods, and Line Pipes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 181 companies including many key and niche players such as Al Jazeera Steel Products Company SAOG, Arabian Pipes Company, ArcelorMittal SA, ERW Pipes Portfolio of ArcelorMittal ChelPipe, Choo Bee Metal Industries Berhad, EVRAZ North America, JFE Steel Corporation, Maharashtra Seamless Limited, Melewar Industrial Group Berhad, Nippon Steel & Sumitomo Metal Corporation, Northwest Pipe Company, OAO TMK, TMK IPSCO, PT Bakrie Pipe Industries, Salzgitter Mannesmann Line Pipe GmbH, Tata Steel Europe, Techint Group SpA, Tenaris S.A., TenarisSiderca, Ternium S.A., United States Steel Corporation, United Metallurgical Company /OMK, Welspun Corp Ltd., Wheatland Tube Company, and Select Products of Wheatland Tube Company. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
This report analyzes the worldwide markets for Wireless Gaming in US$ Million by the following Product Segments: Messaging Based Wireless Gaming, Browser/Web Based Wireless Gaming, and Downloadable Wireless Gaming. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 90 companies including many key and niche players such as Blockdot, Inc., DeNA Co., Ltd., Electronic Arts, Inc., Gameloft SA,GAMEVIL, GREE International, Inc., Glu Mobile Inc., GigaMedia Limited, HandyGames, I-play, Itsmy
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
Hyperalgesia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Hyperalgesia Global Clinical Trials Review, H1, 2013" provides data on the Hyperalgesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperalgesia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperalgesia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
Genital Herpes Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Genital Herpes Global Clinical Trials Review, H1, 2013" provides data on the Genital Herpes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Genital Herpes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Genital Herpes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
Overview: There are a number of technologies that may be deployed that all provide the ability for devices to "discover" one another, although over different distances ranging from centimeters (Near Field Communications), to meters (Bluetooth), to 10s of meters (Wi-Fi). They also all provide the ability for the devices to communicate directly with one another without a centralized network. Some of these use direct communication as their primary mode of communication e.g. NFC or RFID. Others are more traditional networks which provide direct communication ability as an adjunct to their primary network functions e.g. LTE-Direct or Wi-Fi Direct. Most of the short-term drivers for proximity-based services will be mobile advertising and social networking, especially friend-finder services or dating services, and gaming. In the longer term, other applications will come into play within the scope of the so called Internet of Things. The challenge and opportunity for network operators will be to develop new user scenarios and even new business models to generate revenues from these services. This research uncovers opportunities that will be both beneficial and disruptive to the existing ecosystem and value chain. This research is must reading for any company that is considering offerings within proximity and direct communications and any company that wants to stay ahead of the crowd in terms of preparation for these disruptive technologies. Target Audience: ' Mobile network operators' Industry verticals of all types' Wireless device manufacturers' Network infrastructure companies' Advertising agencies, brands, and merchants' Social networks, advertising, and content providers' Proximity, location, and direct communications vendors Key Report Benefits: ' Market forecasts for each significant technology/solution approach' Recognize the upcoming role and importance of LTE Direct compared to other solutions' Analysis of the major vendors focused on proximity and direct communications solutions' Understand the relationship between proximity, direct communications and the Internet of Things' Understand the technical and business-related differences between proximity/presence and location' Identify each of the major technologies/solutions for proximity detection, location determination, and direct communications' Evaluation of the market for major applications including public safety, social networking, advertising, the Internet of Things, and general location services Select Companies in Report: ' 3M Company' Alcatel-Lucent' iSIGN' LG' Nokia' Samsung' Qualcomm' Verizon Wireless
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
This document provides a summary and table of contents for a 900-page report analyzing the clinical chemistry and immunodiagnostic markets in five major European countries. The report explores trends, evaluates competitors, and identifies opportunities in these evolving markets. It contains estimates of test volumes, sales forecasts by category and country, and competitive profiles of leading suppliers.
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
Bradycardia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Bradycardia Global Clinical Trials Review, H1, 2013" provides data on the Bradycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bradycardia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bradycardia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013" provides data on the Acid Indigestion / Heartburn/ Pyrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acid Indigestion / Heartburn/ Pyrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acid Indigestion / Heartburn/ Pyrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
This document is a report on the China iron ore mining industry in 2013. It provides an overview of the industry, including its definition and development history. It analyzes the macroeconomic environment and discusses factors like policy, upstream/downstream industries. It also examines the international and domestic markets. Key data on the industry from 2008-2012 is presented, including numbers of enterprises, employees, assets, output, sales, profits and trade. The competitive landscape and strategies of major companies are evaluated. The report concludes with discussions of development trends, investment environment and new technologies in the industry.
1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
European Markets for Cardiac Surgery Devices
Published on June 2011
Report Summary
In 2010, the European market for cardiac surgery devices was valued at over
'990 million
The European markets for cardiac surgery devices includes:
- Mechanical Heart Valves
- Annuloplasty Repair Devices
- Percutaneous Mitral Valve Repair Devices (PMVR)
- Percutaneous Aortic Valve Replacement Devices (PAVR)
- ONCAB Devices
- OPCAB Devices
- Endoscopic Vessel Harvesting Devices
- Anastomosis Assist Devices
- Cardiac Ablation Devices
- Transmyocardial Revascularization Devices
- Ventricular Assist Devices
- Intra-Aortic Balloon Pump Devices
- Artificial Heard Devices
- Patient Foramen Ovale Devices
- Atrial and Ventricular Septal Devices
The countries covered in this report include:
- Germany
- France
- U.K
- Italy
- Spain
- Benelux
- Scandinavia
- Portugal
- Austria
- Switzerland
Within the European cardiac surgery device market, companies such as Edwards Lifesciences, Maquet, Medtronic, Sorin and St.
Jude lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device
type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive
analysis, including manufacturer market shares and product portfolios.
The executive summary of this report is also available for purchase.
European Markets for Cardiac Surgery Devices (From Slideshare) Page 1/18
2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table of Content
TABLE OF CONTENTS
TABLE OF CONTENTS.I
LIST OF FIGURES.IX
LIST OF CHARTS.. XXVIII
EXECUTIVE SUMMARY 1
1.1 TOTAL EUROPEAN CARDIAC SURGERY MARKET 1
1.2 TISSUE HEART VALVE MARKET.. 2
1.3MECHANICAL HEART VALVE MARKET 2
1.4 ANNULOPLASTY REPAIR DEVICE MARKET 2
1.5 PMVR AND PAVR DEVICE MARKET 3
1.6 ONCAB DEVICE MARKET.. 4
1.7 OPCAB DEVICE MARKET .. 5
1.8 ENDOSCOPIC VESSEL HARVESTING DEVICE MARKET . 5
1.9 ANASTOMOSIS ASSIST DEVICE MARKET. 6
1.10 CARDIAC ABLATION DEVICE MARKET . 6
1.11 TRANSMYOCARDIAL REVASCULARIZATION DEVICE MARKET . 6
1.12 VENTRICULAR ASSIST DEVICE MARKET.. 7
1.13 INTRA-AORTIC BALLOON PUMP DEVICE MARKET . 8
1.14 ARTIFICIAL HEART DEVICE MARKET. 8
1.15 PFO, ASD AND VSD DEVICE MARKET. 8
1.16 COMPETITIVE ANALYSIS .. 9
RESEARCH METHODOLOGY 10
2.1 RESEARCH SCOPE . 10
2.2 IDATA'S 9-STEP METHODOLOGY . 10
Step 1: Project Initiation & Team Selection 11
Step 2: Prepare Data Systems and Perform Secondary Research 12
Step 3: Preparation for Interviews & Questionnaire Design . 13
Step 4: Performing Primary Research 14
Step 5: Research Analysis: Establishing Baseline Estimates . 16
Step 6: Market Forecast and Analysis 16
Step 7: Identify Strategic Opportunities 18
Step 8: Final Review and Market Release 19
Step 9: Customer Feedback and Market Monitoring.. 20
EUROPEAN CARDIAC SURGERY MARKETS .. 21
3.1 INTRODUCTION .. 21
3.2 CURRENCY EXCHANGE RATES .. 23
3.3MARKET OVERVIEW 24
3.4MARKET BY SEGMENT 27
3.5 TREND ANALYSIS BY SEGMENT 35
3.6MARKET BY COUNTRY .. 39
European Markets for Cardiac Surgery Devices (From Slideshare) Page 2/18
3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
3.6.1 Total Market 39
3.6.2 Germany. 44
3.6.3 France. 51
3.6.4 U.K 58
3.6.5 Italy .. 65
3.6.6 Spain 72
3.6.7 Benelux .. 79
3.6.8 Scandinavia.. 86
3.6.9 Portugal . 93
3.6.10 Austria 100
3.6.11 Switzerland.. 107
3.7MARKET DRIVERS AND LIMITERS . 114
3.7.1 Market Drivers. 114
3.7.2 Market Limiters 115
3.8 COMPETITIVE ANALYSIS 117
COUNTRY PROFILES. 129
4.1 INTRODUCTION 129
4.1.1 Population.. 129
4.1.2 GDP per Capita .. 132
4.1.3 Price Index. 134
4.2 GERMANY.. 135
4.3 FRANCE 136
4.4 U.K. .. 137
4.5 ITALY 138
4.6 SPAIN 139
4.7 BENELUX 140
4.8 SCANDINAVIA .. 141
4.9 PORTUGAL . 142
4.10 AUSTRIA .. 143
4.11 SWITZERLAND 144
TISSUE HEART VALVE MARKET 145
5.1 INTRODUCTION 145
5.1.1 Stented versus Stentless Tissue Valves. 146
5.2MARKET OVERVIEW. 147
5.3 PROCEDURES. 154
5.3.1 Procedures by Valve Type . 154
5.3.2 Procedures by Valve Design. 156
5.3.3 Procedures by Tissue Type 159
5.4MARKET ANALYSIS AND FORECAST 161
5.4.1 Total Tissue Heart Valve Market by Country .. 161
5.4.2 Stented Tissue Heart Valve Market by Country.. 169
5.4.3 Stentless Tissue Heart Valve Market by Country 176
5.5MARKET DRIVERS AND LIMITERS . 183
5.5.1 Market Drivers. 183
5.5.2 Market Limiters 184
5.6 COMPETITIVE ANALYSIS 185
MECHANICAL HEART VALVE MARKET. 188
6.1 INTRODUCTION 188
European Markets for Cardiac Surgery Devices (From Slideshare) Page 3/18
4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
6.2 PROCEDURES. 189
6.2.1 Procedures by Valve Type . 189
6.3MARKET ANALYSIS AND FORECAST 192
6.4 DRIVERS AND LIMITERS . 200
6.4.1 Market Drivers. 200
6.4.2 Market Limiters 201
6.5 COMPETITIVE ANALYSIS 202
ANNULOPLASTY REPAIR DEVICE MARKET .. 205
7.1 INTRODUCTION 205
7.2 PROCEDURES. 206
7.3MARKET ANALYSIS AND FORECAST 209
7.4 DRIVERS AND LIMITERS . 216
7.4.1 Market Drivers. 216
7.4.2 Market Limiters 216
7.5 COMPETITIVE ANALYSIS 218
PERCUTANEOUS MITRAL VALVE REPAIR MARKET.. 221
8.1 INTRODUCTION 221
8.2MARKET ANALYSIS AND FORECAST 222
8.3 DRIVERS AND LIMITERS . 225
8.3.1 Market Drivers. 225
8.3.2 Market Limiters 225
8.4 COMPETITIVE ANALYSIS 227
PERCUTANEOUS AORTIC VALVE REPLACEMENT MARKET . 230
9.1 INTRODUCTION 230
9.2MARKET ANALYSIS AND FORECAST 231
9.3 DRIVERS AND LIMITERS . 234
9.3.1 Market Drivers. 234
9.3.2 Market Limiters 235
9.4 COMPETITIVE ANALYSIS 236
ON-PUMP CORONARY ARTERY BYPASS DEVICE MARKET . 240
10.1 INTRODUCTION . 240
10.2 ONCAB PROCEDURES.. 241
10.3MARKET OVERVIEW.. 243
10.4MARKET ANALYSIS AND FORECAST . 248
10.4.1 ONCAB Market by Country 248
10.4.2 ONCAB Disposable Device Market by Country.. 252
10.4.3 ONCAB Perfusion Device Market by Country . 259
10.5MARKET DRIVERS AND LIMITERS .. 266
10.5.1 Market Drivers.. 266
10.5.2 Market Limiters. 267
10.6 COMPETITIVE ANALYSIS . 268
OFF-PUMP CORONARY ARTERY BYPASS DEVICE MARKET .. 271
11.1 INTRODUCTION . 271
11.2MARKET OVERVIEW.. 272
11.3 PROCEDURES.. 278
11.3.1 OPCAB Procedures 278
11.4MARKET ANALYSIS AND FORECAST . 280
11.4.1 OPCAB Market by Country 280
European Markets for Cardiac Surgery Devices (From Slideshare) Page 4/18
6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
15.4.1 Market Drivers.. 406
15.4.2 Market Limiters. 407
15.5 COMPETITIVE ANALYSIS . 408
VENTRICULAR ASSIST DEVICE MARKET . 410
16.1 INTRODUCTION . 410
16.2MARKET OVERVIEW.. 412
16.3MARKET ANALYSIS AND FORECAST . 419
16.3.1 Ventricular Assist Device Market by Country .. 419
16.3.2 Percutaneous Ventricular Assist Device Market by Country 423
16.3.3 Bridge-to-Recovery Ventricular Assist Device Market by Country 430
16.3.4 Bridge-to-Transplant Ventricular Assist Device Market by Country 437
16.3.5 Destination Therapy Ventricular Assist Device Market by Country . 444
16.4MARKET DRIVERS AND LIMITERS .. 451
16.4.1 Market Drivers.. 451
16.4.2 Market Limiters. 452
16.5 COMPETITIVE ANALYSIS . 453
INTRA-AORTIC BALLOON PUMP DEVICE MARKET 457
17.1 INTRODUCTION . 457
17.2MARKET OVERVIEW.. 458
17.3 IABP PROCEDURES. 463
17.4MARKET ANALYSIS AND FORECAST . 465
17.4.1 Intra-Aortic Balloon Pump Device Market by Country 465
17.4.2 Disposable Intra-Aortic Balloon Pump Device Market by Country.. 467
17.4.3 Intra-Aortic Balloon Pump Console Device Market.. 474
17.5MARKET DRIVERS AND LIMITERS .. 476
17.5.1 Market Drivers.. 476
17.5.2 Market Limiters. 476
17.6 COMPETITIVE ANALYSIS . 478
ARTIFICIAL HEART DEVICE MARKET. 481
18.1 INTRODUCTION . 481
18.2MARKET OVERVIEW.. 482
18.3 PROCEDURES.. 488
18.3.1 Artificial Heart Device Procedures 488
18.4MARKET ANALYSIS AND FORECAST . 489
18.4.1 Temporary Artificial Heart Device Market by Country 491
18.4.2 Permanent Artificial Heart Device Market by Country 497
18.5MARKET DRIVERS AND LIMITERS .. 499
18.5.1 Market Drivers.. 499
18.5.2 Market Limiters. 499
18.6 COMPETITIVE ANALYSIS . 501
PATENT FORAMEN OVALE DEVICE MARKET.. 502
19.1 INTRODUCTION . 502
19.2MARKET ANALYSIS AND FORECAST . 503
19.3 DRIVERS AND LIMITERS .. 511
19.3.1 Market Drivers.. 511
19.3.2 Market Limiters. 511
19.4 COMPETITIVE ANALYSIS . 513
ATRIAL AND VENTRICULAR SEPTAL DEVICE MARKET 516
European Markets for Cardiac Surgery Devices (From Slideshare) Page 6/18
7. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
20.1 INTRODUCTION . 516
20.2MARKET ANALYSIS AND FORECAST . 517
20.3 DRIVERS AND LIMITERS .. 525
20.3.1 Market Drivers.. 525
20.3.2 Market Limiters. 525
20.4 COMPETITIVE ANALYSIS . 527
ABBREVIATIONS 530
LIST OF FIGURES
EXECUTIVE SUMMARY 1
RESEARCH METHODOLOGY.. 10
EUROPEAN CARDIAC SURGERY MARKETS. 21
Figure 3-1: Exchange Rate for the Euro ('), 2010 .. 23
Figure 3-2: Total Cardiac Surgery Market, Europe, 2007 ' 2017 ('M).. 24
Figure 3-3: Total Cardiac Surgery Market, Europe, 2007 ' 2017 (US$M) 24
Figure 3-4: Total Cardiac Surgery Market by Segment, Europe, 2007 ' 2017 ('M)
(Part 1 of 2) 28
Figure 3-5: Total Cardiac Surgery Market by Segment, Europe, 2007 ' 2017 ('M)
(Part 2 of 2) 29
Figure 3-6: Total Cardiac Surgery Market by Segment, Europe, 2007 ' 2017
(US$M) (Part 1 of 2) . 30
Figure 3-7: Total Cardiac Surgery Market by Segment, Europe, 2007 ' 2017
(US$M) (Part 2 of 2) . 31
Figure 3-8: Growth Rates by Segment, Cardiac Surgery Market, Europe,
2007 ' 2017 (Part 1 of 2) . 36
Figure 3-9: Growth Rates by Segment, Cardiac Surgery Market, Europe,
2007 ' 2017 (Part 2 of 2) . 37
Figure 3-10: Total Cardiac Surgery Market by Country, Europe, 2007 ' 2017
('M).. 40
Figure 3-11: Total Cardiac Surgery Market by Country, Europe, 2007 ' 2017
(US$M) 41
Figure 3-12: Total Cardiac Surgery Market by Segment, Germany, 2007 ' 2017
('M) (Part 1 of 2) 45
Figure 3-13: Total Cardiac Surgery Market by Segment, Germany, 2007 ' 2017
('M) (Part 2 of 2) 46
Figure 3-14: Total Cardiac Surgery Market by Segment, Germany, 2007 ' 2017
(US$M) (Part 1 of 2) . 47
Figure 3-15: Total Cardiac Surgery Market by Segment, Germany, 2007 ' 2017
(US$M) (Part 2 of 2) . 48
Figure 3-16: Total Cardiac Surgery Market by Segment, France, 2007 ' 2017
('M) (Part 1 of 2) 52
Figure 3-17: Total Cardiac Surgery Market by Segment, France, 2007 ' 2017
('M) (Part 2 of 2) 53
Figure 3-18: Total Cardiac Surgery Market by Segment, France, 2007 ' 2017
(US$M) (Part 1 of 2) . 54
Figure 3-19: Total Cardiac Surgery Market by Segment, France, 2007 ' 2017
(US$M) (Part 2 of 2) . 55
European Markets for Cardiac Surgery Devices (From Slideshare) Page 7/18
8. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Figure 3-20: Total Cardiac Surgery Market by Segment, U.K., 2007 ' 2017 ('M)
(Part 1 of 2) 59
Figure 3-21: Total Cardiac Surgery Market by Segment, U.K., 2007 ' 2017 ('M)
(Part 2 of 2) 60
Figure 3-22: Total Cardiac Surgery Market by Segment, U.K., 2007 ' 2017
(US$M) (Part 1 of 2) . 61
Figure 3-23: Total Cardiac Surgery Market by Segment, U.K., 2007 ' 2017
(US$M) (Part 2 of 2) . 62
Figure 3-24: Total Cardiac Surgery Market by Segment, Italy, 2007 ' 2017 ('M)
(Part 1 of 2) 66
Figure 3-25: Total Cardiac Surgery Market by Segment, Italy, 2007 ' 2017 ('M)
(Part 2 of 2) 67
Figure 3-26: Total Cardiac Surgery Market by Segment, Italy, 2007 ' 2017
(US$M) (Part 1 of 2) . 68
Figure 3-27: Total Cardiac Surgery Market by Segment, Italy, 2007 ' 2017
(US$M) (Part 2 of 2) . 69
Figure 3-28: Total Cardiac Surgery Market by Segment, Spain, 2007 ' 2017 ('M)
(Part 1 of 2) 73
Figure 3-29: Total Cardiac Surgery Market by Segment, Spain, 2007 ' 2017 ('M)
(Part 2 of 2) 74
Figure 3-30: Total Cardiac Surgery Market by Segment, Spain, 2007 ' 2017
(US$M) (Part 1 of 2) . 75
Figure 3-31: Total Cardiac Surgery Market by Segment, Spain, 2007 ' 2017
(US$M) (Part 2 of 2) . 76
Figure 3-32: Total Cardiac Surgery Market by Segment, Benelux, 2007 ' 2017
('M) (Part 1 of 2) 80
Figure 3-33: Total Cardiac Surgery Market by Segment, Benelux, 2007 ' 2017
('M) (Part 2 of 2) 81
Figure 3-34: Total Cardiac Surgery Market by Segment, Benelux, 2007 ' 2017
(US$M) (Part 1 of 2) . 82
Figure 3-35: Total Cardiac Surgery Market by Segment, Benelux, 2007 ' 2017
(US$M) (Part 2 of 2) . 83
Figure 3-36: Total Cardiac Surgery Market by Segment, Scandinavia,
2007 ' 2017 ('M) (Part 1 of 2) . 87
Figure 3-37: Total Cardiac Surgery Market by Segment, Scandinavia,
2007 ' 2017 ('M) (Part 2 of 2) . 88
Figure 3-38: Total Cardiac Surgery Market by Segment, Scandinavia,
2007 ' 2017 (US$M) (Part 1 of 2) 89
Figure 3-39: Total Cardiac Surgery Market by Segment, Scandinavia,
2007 ' 2017 (US$M) (Part 2 of 2) 90
Figure 3-40: Total Cardiac Surgery Market by Segment, Portugal, 2007 ' 2017
('M) (Part 1 of 2) 94
Figure 3-41: Total Cardiac Surgery Market by Segment, Portugal, 2007 ' 2017
('M) (Part 2 of 2) 95
Figure 3-42: Total Cardiac Surgery Market by Segment, Portugal, 2007 ' 2017
(US$M) (Part 1 of 2) . 96
Figure 3-43: Total Cardiac Surgery Market by Segment, Portugal, 2007 ' 2017
(US$M) (Part 2 of 2) . 97
European Markets for Cardiac Surgery Devices (From Slideshare) Page 8/18
9. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Figure 3-44: Total Cardiac Surgery Market by Segment, Austria, 2007 ' 2017
('M) (Part 1 of 2) . 101
Figure 3-45: Total Cardiac Surgery Market by Segment, Austria, 2007 ' 2017
('M) (Part 2 of 2) . 102
Figure 3-46: Total Cardiac Surgery Market by Segment, Austria, 2007 ' 2017
(US$M) (Part 1 of 2) .. 103
Figure 3-47: Total Cardiac Surgery Market by Segment, Austria, 2007 ' 2017
(US$M) (Part 2 of 2) .. 104
Figure 3-48: Total Cardiac Surgery Market by Segment, Switzerland,
2007 ' 2017 ('M) (Part 1 of 2) .. 108
Figure 3-49: Total Cardiac Surgery Market by Segment, Switzerland,
2007 ' 2017 ('M) (Part 2 of 2) .. 109
Figure 3-50: Total Cardiac Surgery Market by Segment, Switzerland,
2007 ' 2017 (US$M) (Part 1 of 2) . 110
Figure 3-51: Total Cardiac Surgery Market by Segment, Switzerland,
2007 ' 2017 (US$M) (Part 2 of 2) . 111
Figure 3-52: Drivers and Limiters, Cardiac Surgery Market, Europe, 2010 .. 116
Figure 3-53: Leading Competitors, Cardiac Surgery Market, Europe, 2010
(Part 1 of 4) . 124
Figure 3-54: Leading Competitors, Cardiac Surgery Market, Europe, 2010
(Part 2 of 4) . 125
Figure 3-55: Leading Competitors, Cardiac Surgery Market, Europe, 2010
(Part 3 of 4) . 126
Figure 3-56: Leading Competitors, Cardiac Surgery Market, Europe, 2010
(Part 4 of 4) . 127
COUNTRY PROFILES 129
Figure 4-1: Total Population, Europe, 2010 129
Figure 4-2: Population, Benelux, 2010. 130
Figure 4-3: Population, Scandinavia, 2010 . 130
Figure 4-4: GDP per Capita, Europe, 2010 .. 132
Figure 4-5: Country Indicators, 2010 . 134
TISSUE HEART VALVE MARKET.. 145
Figure 5-1: Tissue Heart Valve Units Sold by Segment, Europe, 2007 ' 2017. 148
Figure 5-2: Tissue Heart Valve ASP by Segment, Europe, 2007 ' 2017 (').. 149
Figure 5-3: Tissue Heart Valve ASP by Segment, Europe, 2007 ' 2017 (US$) 149
Figure 5-4: Total Tissue Heart Valve Market by Segment, Europe, 2007 ' 2017
('M) 150
Figure 5-5: Total Tissue Heart Valve Market by Segment, Europe, 2007 ' 2017
(US$M) . 150
Figure 5-6: Tissue Valve Replacement Procedure Percentages by Valve Type,
Europe, 2007 ' 2017 154
Figure 5-7: Total Tissue Heart Valve Procedures by Country, Europe,
2007 ' 2017. 155
Figure 5-8: Tissue Valve Replacement Procedure Percentages by Device Type,
Europe, 2007 ' 2017 156
Figure 5-9: Stented Tissue Heart Valve Procedures by Country, Europe,
2007 ' 2017. 157
Figure 5-10: Stentless Tissue Heart Valve Procedures by Country, Europe,
European Markets for Cardiac Surgery Devices (From Slideshare) Page 9/18
10. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
2007 ' 2017. 158
Figure 5-11: Tissue Valve Replacement Procedure by Tissue Type, Europe, 2007
' 2017 160
Figure 5-12: Total Tissue Heart Valve Market, Europe, 2007 ' 2017 (') .. 163
Figure 5-13: Total Tissue Heart Valve Market, Europe, 2007 ' 2017 (US$) . 163
Figure 5-14: Tissue Heart Valve Units Sold by Country, Europe, 2007 ' 2017 164
Figure 5-15: Tissue Heart Valve ASP by Country, Europe, 2007 ' 2017 ('). 165
Figure 5-16: Tissue Heart Valve ASP by Country, Europe, 2007 ' 2017 (US$) .. 166
Figure 5-17: Total Tissue Heart Valve Market by Country, Europe, 2007 ' 2017
('M) 167
Figure 5-18: Total Tissue Heart Valve Market by Country, Europe, 2007 ' 2017
(US$M) . 168
Figure 5-19: Stented Tissue Heart Valve Market, Europe, 2007 ' 2017 (') .. 170
Figure 5-20: Stented Tissue Heart Valve Market, Europe, 2007 ' 2017 (US$). 170
Figure 5-21: Stented Tissue Heart Valve Units Sold by Country, Europe,
2007 ' 2017. 171
Figure 5-22: Stented Tissue Heart Valve ASP by Country, Europe, 2007 ' 2017
(') 172
Figure 5-23: Stented Tissue Heart Valve ASP by Country, Europe, 2007 ' 2017
(US$) . 173
Figure 5-24: Stented Tissue Heart Valve Market by Country, Europe,
2007 ' 2017 ('M) . 174
Figure 5-25: Stented Tissue Heart Valve Market by Country, Europe,
2007 ' 2017 (US$M) .. 175
Figure 5-26: Stentless Tissue Heart Valve Market, Europe, 2007 ' 2017 (') 177
Figure 5-27: Stentless Tissue Heart Valve Market, Europe, 2007 ' 2017 (US$) . 177
Figure 5-28: Stentless Tissue Heart Valve Units Sold by Country, Europe,
2007 ' 2017. 178
Figure 5-29: Stentless Tissue Heart Valve ASP by Country, Europe, 2007 ' 2017
(') 179
Figure 5-30: Stentless Tissue Heart Valve ASP by Country, Europe, 2007 ' 2017
(US$) . 180
Figure 5-31: Stentless Tissue Heart Valve Market by Country, Europe,
2007 ' 2017 ('M) . 181
Figure 5-32: Stentless Tissue Heart Valve Market by Country, Europe,
2007 ' 2017 (US$M) .. 182
Figure 5-33: Drivers and Limiters, Tissue Heart Valve Market, Europe, 2010. 184
Figure 5-34: Leading Competitors, Tissue Heart Valve Market, Europe, 2010 186
MECHANICAL HEART VALVE MARKET.. 188
Figure 6-1: Mechanical Valve Replacement Procedure Percentages by Valve
Type, Europe, 2007 ' 2017 .. 190
Figure 6-2: Mechanical Heart Valve Procedures by Country, Europe,
2007 ' 2017. 191
Figure 6-3: Mechanical Heart Valve Market, Europe, 2007 ' 2017 (') 193
Figure 6-4: Mechanical Heart Valve Market, Europe, 2007 ' 2017 (US$) . 193
Figure 6-5: Mechanical Heart Valve Units Sold by Country, Europe,
2007 ' 2017. 195
Figure 6-6: Mechanical Heart Valve ASP by Country, Europe, 2007 ' 2017 (') . 196
European Markets for Cardiac Surgery Devices (From Slideshare) Page 10/18
13. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Figure 11-13: OPCAB Stabilizer Device Units Sold by Country, Europe,
2007 ' 2017. 286
Figure 11-14: OPCAB Stabilizer Device ASP by Country, Europe, 2007 ' 2017
(') 287
Figure 11-15: OPCAB Stabilizer Device ASP by Country, Europe, 2007 ' 2017
(US$) . 288
Figure 11-16: OPCAB Stabilizer Device Market by Country, Europe, 2007 ' 2017
('M) 289
Figure 11-17: OPCAB Stabilizer Device Market by Country, Europe, 2007 ' 2017
(US$M) . 290
Figure 11-18: OPCAB Positioner and Accessory Device Market, Europe,
2007 ' 2017 (') . 292
Figure 11-19: OPCAB Positioner and Accessory Device Market, Europe,
2007 ' 2017 (US$) 292
Figure 11-20: OPCAB Positioner and Accessory Device Units Sold by Country,
Europe, 2007 ' 2017 293
Figure 11-21: OPCAB Positioner and Accessory Device ASP by Country, Europe,
2007 ' 2017 (') . 294
Figure 11-22: OPCAB Positioner and Accessory Device ASP by Country, Europe,
2007 ' 2017 (US$) 295
Figure 11-23: OPCAB Positioner and Accessory Device Market by Country,
Europe, 2007 ' 2017 ('M) 296
Figure 11-24: OPCAB Positioner and Accessory Device Market by Country,
Europe, 2007 ' 2017 (US$M).. 297
Figure 11-25: Drivers and Limiters, OPCAB Market, Europe, 2010 . 299
Figure 11-26: Leading Competitors, OPCAB Market, Europe, 2010 301
ENDOSCOPIC VESSEL HARVESTING DEVICE MARKET. 303
Figure 12-1: CABG Vessel Harvesting by Type, Europe, 2007 ' 2017 .. 304
Figure 12-2: Endoscopic Vessel Harvesting Device Procedures by Country,
Market, Europe, 2007 ' 2017 .. 305
Figure 12-3: Endoscopic Vessel Harvesting Device Market, Europe, 2007 ' 2017
(') 307
Figure 12-4: Endoscopic Vessel Harvesting Device Market, Europe, 2007 ' 2017
(US$) . 307
Figure 12-5: Endoscopic Vessel Harvesting Device Units Sold by Country,
Europe, 2007 ' 2017 309
Figure 12-6: Endoscopic Vessel Harvesting Device ASP by Country, Europe,
2007 ' 2017 (') . 310
Figure 12-7: Endoscopic Vessel Harvesting Device ASP by Country, Europe,
2007 ' 2017 (US$) 311
Figure 12-8: Endoscopic Vessel Harvesting Device Market by Country, Europe,
2007 ' 2017 ('M) . 312
Figure 12-9: Endoscopic Vessel Harvesting Device Market by Country, Europe,
2007 ' 2017 (US$M) .. 313
Figure 12-10: Drivers and Limiters, Endoscopic Vessel Harvesting Device
Market, Europe, 2010 . 314
Figure 12-11: Leading Competitors, Endoscopic Vessel Harvesting Device
Market, Europe, 2010 . 316
European Markets for Cardiac Surgery Devices (From Slideshare) Page 13/18
14. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
ANASTOMOSIS ASSIST DEVICE MARKET .. 318
Figure 13-1: CABG Procedures by Suture Type, Europe, 2007 ' 2017 320
Figure 13-2: Anastomosis Assist Device Procedures by Country, Europe,
2007 ' 2017. 321
Figure 13-3: Anastomosis Assist Device Market, Europe, 2007 ' 2017 (') .. 323
Figure 13-4: Anastomosis Assist Device Market, Europe, 2007 ' 2017 (US$). 323
Figure 13-5: Anastomosis Assist Device Units Sold by Country, Europe,
2007 ' 2017. 325
Figure 13-6: Anastomosis Assist Device ASP by Country, Europe, 2007 ' 2017
(') 326
Figure 13-7: Anastomosis Assist Device ASP by Country, Europe, 2007 ' 2017
(US$) . 327
Figure 13-8: Anastomosis Assist Device Market by Country, Europe, 2007 ' 2017
('M) 328
Figure 13-9: Anastomosis Assist Device Market by Country, Europe, 2007 ' 2017
(US$M) . 329
Figure 13-10: Drivers and Limiters, Anastomosis Assist Device Market, Europe,
2010 331
Figure 13-11: Leading Competitors, Anastomosis Assist Device Market, Europe,
2010 333
CARDIAC ABLATION DEVICE MARKET .. 335
Figure 14-1: Cardiac Ablation Procedures by Type, Europe, 2007 ' 2017 . 339
Figure 14-2: Cardiac Ablation Procedures by Country, Europe, 2007 ' 2017 .. 340
Figure 14-3: Catheter-Based Cardiac Ablation Procedures for the Treatment of
Atrial Fibrillation by Country, Europe, 2007 ' 2017 . 342
Figure 14-4: Cardiac Ablation Procedures by Method of Catheter Steering,
Europe, 2007 ' 2017 343
Figure 14-5: Total Cardiac Ablation Units Sold by Segment, Europe,
2007 ' 2017. 345
Figure 14-6: Proportion of Cardiac Ablation Catheters by Segment, Europe, 2007
' 2017 346
Figure 14-7: Total Cardiac Ablation Device ASP by Segment, Europe,
2007 ' 2017 (') . 347
Figure 14-8: Total Cardiac Ablation Catheter ASP by Segment, Europe,
2007 ' 2017 (US$) 348
Figure 14-9: Total Cardiac Ablation Catheter Market by Segment, Europe,
2007 ' 2017 ('M) . 349
Figure 14-10: Total Cardiac Ablation Catheter Market by Segment, Europe,
2007 ' 2017 (US$M) .. 350
Figure 14-11: RF Cardiac Ablation Catheter Market, Europe, 2007 ' 2017 (') 355
Figure 14-12: RF Cardiac Ablation Catheter Market, Europe, 2007 ' 2017
(US$) . 355
Figure 14-13: Irrigated RF Cardiac Ablation Catheter Market, Europe,
2007 ' 2017 (') . 357
Figure 14-14: Irrigated RF Cardiac Ablation Catheter Market, Europe,
2007 ' 2017 (US$) 357
Figure 14-15: Total Irrigated RF Cardiac Ablation Catheter Units Sold by
Country, Europe, 2007 ' 2017. 358
European Markets for Cardiac Surgery Devices (From Slideshare) Page 14/18
15. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Figure 14-16: Irrigated RF Cardiac Ablation Catheter ASP by Country, Europe,
2007 ' 2017 (') . 359
Figure 14-17: Irrigated RF Cardiac Ablation Catheter ASP by Country, Europe,
2007 ' 2017 (US$) 360
Figure 14-18: Irrigated RF Cardiac Ablation Catheter Market Value by Country,
Europe, 2007 ' 2017 ('M) .. 361
Figure 14-19: Irrigated RF Cardiac Ablation Catheter Market Value by Country,
Europe, 2007 ' 2017 (US$M). 362
Figure 14-20: Non-Irrigated RF Cardiac Ablation Catheter Market, Europe, 2007
' 2017 ('). 364
Figure 14-21: Non-Irrigated RF Cardiac Ablation Catheter Market, Europe,
2007 ' 2017 (US$) 364
Figure 14-22: Total Non-Irrigated RF Cardiac Ablation Catheter Units Sold by
Country, Europe, 2007 ' 2017. 365
Figure 14-23: Non-Irrigated RF Cardiac Ablation Catheter ASP by Country,
Europe, 2007 ' 2017 (') 366
Figure 14-24: Non-Irrigated RF Cardiac Ablation Catheter ASP by Country,
Europe, 2007 ' 2017 (US$).. 367
Figure 14-25: Non-Irrigated RF Cardiac Ablation Catheter Market Value by
Country, Europe, 2007 ' 2017 ('M) . 368
Figure 14-26: Non-Irrigated RF Cardiac Ablation Catheter Market Value by
Country, Europe, 2007 ' 2017 (US$M) .. 369
Figure 14-27: Cryoablation Catheter Market, Europe, 2007 ' 2017 (') .. 371
Figure 14-28: Cryoablation Catheter Market, Europe, 2007 ' 2017 (US$). 371
Figure 14-29: Cryoablation Catheter Units Sold by Country, Europe,
2007 ' 2017. 372
Figure 14-30: Cryoablation Catheter ASP by Country, Europe, 2007 ' 2017 (') 373
Figure 14-31: Cryoablation Catheter ASP by Country, Europe, 2007 ' 2017
(US$) . 374
Figure 14-32: Cryoablation Catheter Market by Country, Europe, 2007 ' 2017
('M) 375
Figure 14-33: Cryoablation Catheter Market Value by Country, Europe,
2007 ' 2017 (US$M) .. 376
Figure 14-34: Surgical Ablation Market, Europe, 2007 ' 2017 (') 378
Figure 14-35: Surgical Ablation Market, Europe, 2007 ' 2017 (US$) . 378
Figure 14-36: Surgical Ablation Units Sold by Country, Europe, 2007 ' 2017 379
Figure 14-37: Surgical Ablation ASP by Country, Europe, 2007 ' 2017 (') . 380
Figure 14-38: Surgical Ablation ASP by Country, Europe, 2007 ' 2017 (US$) .. 381
Figure 14-39: Surgical Ablation Market Value by Country, Europe, 2007 ' 2017
('M) 382
Figure 14-40: Surgical Ablation Market Value by Country, Europe, 2007 ' 2017
(US$M) . 383
Figure 14-41: Drivers and Limiters, Cardiac Ablation Market, Europe, 2010 .. 387
Figure 14-42: Leading Competitors in the Cardiac Ablation Market, Europe,
2010 391
TRANSMYOCARDIAL REVASCULARIZATION DEVICE MARKET. 393
Figure 15-1: Transmyocardial Revascularization Device Market by Segment,
Europe, 2007 ' 2017 ('M) 395
European Markets for Cardiac Surgery Devices (From Slideshare) Page 15/18
16. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Figure 15-2: Transmyocardial Revascularization Device Market by Segment,
Europe, 2007 ' 2017 (US$M).. 395
Figure 15-3: Transmyocardial Revascularization Device Market, Europe,
2007 ' 2017 ('M) . 399
Figure 15-4: Transmyocardial Revascularization Device Market, Europe,
2007 ' 2017 (US$M) .. 400
Figure 15-5: Disposable TMR Device Market, Europe, 2007 ' 2017 (') 402
Figure 15-6: Disposable TMR Device Market, Europe, 2007 ' 2017 (US$).. 402
Figure 15-7: TMR Laser Capital Equipment Device Market, Europe, 2007 ' 2017
(') 404
Figure 15-8: TMR Laser Capital Equipment Device Market, Europe, 2007 ' 2017
(US$) . 405
Figure 15-9: Drivers and Limiters, Transmyocardial Revascularization Device
Market, Europe, 2010 . 407
Figure 15-10: Leading Competitors, Transmyocardial Revascularization Device
Market, Europe, 2010 . 408
VENTRICULAR ASSIST DEVICE MARKET .. 410
Figure 16-1: Ventricular Assist Device Units Sold by Segment, Europe,
2007 ' 2017. 413
Fi
European Markets for Cardiac Surgery Devices (From Slideshare) Page 16/18
17. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
European Markets for Cardiac Surgery Devices
Product Formats
Please select the product formats and the quantity you require.
Hard Copy--USD 10 995.00 Quantity: _____
1 User License--USD 11 495.00 Quantity: _____
Corporate License--USD 13 995.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
European Markets for Cardiac Surgery Devices (From Slideshare) Page 17/18
18. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
European Markets for Cardiac Surgery Devices (From Slideshare) Page 18/18